ADMA

ADMA Biologics, Inc.

Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$9.19

Market Cap

$2.19B

Beta

0.82

P/E

16.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+19.63%

EPS Growth (YoY)-26.41%

Revenue CAGR 3Y+49.05%

P/E Ratio16.0

PEG Ratio—

FCF Yield+1.27%

Debt / Equity0.17

Interest Coverage26.9x

No credit card required

Already have an account? Sign in to view the full analysis for ADMA.